Presentation
13 March 2024 Enhancing efficacy in hypoxic HNC spheroids with PDT-based combinatorial treatments
Author Affiliations +
Abstract
Head and neck cancer (HNC) presents challenges due to its heterogeneity, high recurrence rate, and hypoxic microenvironments. Current treatments fall short, leading to high morbidity and mortality. Photodynamic therapy (PDT) offers spatiotemporal tumor control but relies on oxygenation, posing limitations in hypoxic tumors. Combining hypoxia-activated prodrugs with PDT can selectively kill hypoxic tumor cells and reduce the tumor burden. This study proposes using evofosfamide, a hypoxia-activated prodrug, in combination with benzoporphyrin derivative (BPD)-PDT in a 3D spheroids model of HNC. The growth profile, BPD uptake profile, and hypoxia development were investigated. Combination therapy enhanced PDT efficacy in hypoxic HNC spheroids.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Marvin Xavierselvan, Vicky Yang, and Srivalleesha Mallidi "Enhancing efficacy in hypoxic HNC spheroids with PDT-based combinatorial treatments", Proc. SPIE PC12823, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXII, PC128230B (13 March 2024); https://doi.org/10.1117/12.3003300
Advertisement
Advertisement
KEYWORDS
Photodynamic therapy

Tumors

3D modeling

Hypoxia

Cancer

Control systems

Head

Back to Top